...
首页> 外文期刊>Medicinal chemistry >A potential andrographolide analogue against the replication of herpes simplex virus Type 1 in vero cells.
【24h】

A potential andrographolide analogue against the replication of herpes simplex virus Type 1 in vero cells.

机译:一种潜在的穿心莲内酯类似物,可抵抗vero细胞中1型单纯疱疹病毒的复制。

获取原文
获取原文并翻译 | 示例

摘要

Andrographolide (AD), and 14-deoxyandrographolide (DAD) isolated from Andrographis paniculata Nees, Acanthaceae, and 3,19-isopropylideneandrographolide (IPAD), a semi-synthetic compound of AD, were examined for anti-HSV-1 activity in vitro. The inhibitory effects of these compounds on viral entry and replication steps were determined using pre- and post-infection assays, respectively. All the three compounds exhibited less than 50% inhibitory act against viral entry. In the post-infection, IPAD displayed absolute inhibition, whereas AD and DAD gave moderate activity. IPAD was selected to determine for the stage of anti-replication by time-of-addition and time-of-removal assays. From the time of removal assay, IPAD activity began after 4 h and completed at 16 h post infection which corresponded to the early genes expression. Its ability to inhibit HSV-1 was confirmed by polymerase chain reaction and the expression of viral glycoproteins C and D by western blot analysis. No viral enveloped glycoproteins D and C expressions were found. IPAD exhibited anti-HSV-1 replication relating to the early step of replication. Structure-activity relationships of andrographolide against HSV-1 was proposed, it is the first report of this ent-labdane diterpene.
机译:从穿心莲(Anrographis paniculata Nees),棘皮科(Acanthaceae)和AD的半合成化合物3,19-异丙基(1,3-异丙基)异穿心莲内酯(IPAD)中分离出的穿心莲内酯(AD)和14-脱氧穿心莲内酯(DAD)在体外具有抗HSV-1活性。分别使用感染前和感染后测定来确定这些化合物对病毒进入和复制步骤的抑制作用。三种化合物均显示出对病毒进入的抑制作用小于50%。在感染后,IPAD表现出绝对抑制作用,而AD和DAD表现出中等活性。通过添加时间和去除时间分析选择IPAD来确定抗复制的阶段。从去除试验开始,IPAD活性在感染后4小时开始,并在感染后16小时完成,这与早期基因表达相对应。通过聚合酶链反应证实了其抑制HSV-1的能力,并通过蛋白质印迹分析证实了病毒糖蛋白C和D的表达。没有发现病毒包膜糖蛋白D和C表达。 IPAD展示了与复制早期有关的抗HSV-1复制。提出了穿心莲内酯对HSV-1的构效关系,这是该对马丹烷二萜的首次报道。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号